Literature DB >> 17430075

Case report: moderate hemolytic disease of the newborn due to anti-G.

A R Huber1, G T Leonard, R W Driggers, S B Learn, C W Gilstad.   

Abstract

Views expressed in this article are those of the author and do not reflect the official policy or position of the Department of the Navy, Department of Defense, or U.S. Government. The only previously published case of anti-G in a pregnant woman indicated that anti-G alone caused little, if any, fetal or neonatal hemolysis. This report describes an affected fetus with amnionitic fluid OD 450 absorbance values in the moderate zone of the Liley prediction graph who required prolonged phototherapy after birth until day of life 20. Anti-G was identified and anti-C and -D excluded in the mother's serum. In contrast to the previous report, this report shows anti-G alone can cause moderate HDN and that fetal monitoring and treatment may be necessary.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17430075

Source DB:  PubMed          Journal:  Immunohematology        ISSN: 0894-203X


  4 in total

1.  Approach to a Pregnant Woman with Anti D + Anti C Reactivity Pattern: A Diagnostic Conundrum.

Authors:  Preeti Rai; Geetika Sharma; Deeksha Singh; Jyoti Garg
Journal:  J Clin Diagn Res       Date:  2017-09-01

2.  Anti-G antibody in alloimmunized pregnant women: Report of two cases.

Authors:  Raj Nath Makroo; Anita Kaul; Aakanksha Bhatia; Soma Agrawal; Chanchal Singh; Prashant Karna
Journal:  Asian J Transfus Sci       Date:  2015 Jul-Dec

3.  Anti-G with concomitant anti-C and anti-D: A case report in a pregnant woman.

Authors:  Rabeya Yousuf; Ahmad Nasirudin Mustafa; Siew-Ling Ho; Yee-Loong Tang; Chooi-Fun Leong
Journal:  Asian J Transfus Sci       Date:  2017 Jan-Jun

4.  Clinical Significance of Anti-G Alloantibody and Serologic Interpretation Strategies for Patients with an Anti-C+D Pattern: First Report of Anti-G Alloantibody Identification in Korea.

Authors:  Da Young Song; Dong Woo Shin; Mi Sook Yoon; Yun Ji Hong; Hyungsuk Kim; Kyou Sup Han
Journal:  Ann Lab Med       Date:  2018-05       Impact factor: 3.464

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.